Wealthfront Advisers’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,193
| Closed | -$413K | – | 874 |
|
|
2024
Q1 | $413K | Sell |
1,193
-130
| -10% | -$45K | ﹤0.01% | 757 |
|
|
2023
Q4 | $427K | Buy |
1,323
+610
| +86% | +$197K | ﹤0.01% | 744 |
|
|
2023
Q3 | $256K | Buy |
+713
| New | +$256K | ﹤0.01% | 784 |
|
|
2023
Q2 | – | Sell |
-585
| Closed | -$280K | – | 825 |
|
|
2023
Q1 | $280K | Buy |
585
+28
| +5% | +$13.4K | ﹤0.01% | 759 |
|
|
2022
Q4 | $234K | Sell |
557
-32
| -5% | -$13.5K | ﹤0.01% | 750 |
|
|
2022
Q3 | $246K | Sell |
589
-388
| -40% | -$162K | ﹤0.01% | 722 |
|
|
2022
Q2 | $484K | Sell |
977
-424
| -30% | -$210K | ﹤0.01% | 599 |
|
|
2022
Q1 | $789K | Buy |
1,401
+108
| +8% | +$60.8K | ﹤0.01% | 557 |
|
|
2021
Q4 | $977K | Sell |
1,293
-15
| -1% | -$11.3K | ﹤0.01% | 496 |
|
|
2021
Q3 | $975K | Buy |
1,308
+23
| +2% | +$17.1K | ﹤0.01% | 476 |
|
|
2021
Q2 | $828K | Sell |
1,285
-49
| -4% | -$31.6K | ﹤0.01% | 457 |
|
|
2021
Q1 | $762K | Sell |
1,334
-149
| -10% | -$85.1K | ﹤0.01% | 411 |
|
|
2020
Q4 | $865K | Buy |
1,483
+330
| +29% | +$192K | 0.01% | 377 |
|
|
2020
Q3 | $594K | Buy |
1,153
+646
| +127% | +$333K | ﹤0.01% | 397 |
|
|
2020
Q2 | $229K | Buy |
+507
| New | +$229K | ﹤0.01% | 482 |
|